Latest News
Rhino Rescue Launches European Office in Novara, Italy, Enhancing Emergency Medical Solutions
NOVARA, Italie, 17 avril 2025 /PRNewswire/ -- Rhino Rescue, fournisseur mondial de solutions médicales d'urgence, a annoncé aujourd'hui l'ouverture officielle de son bureau européen à Novara, en Italie, marquant ainsi une étape importante dans son engagement à mieux servir le marché...
Mass Recall Issued for Portable Power Banks Due to Fire Hazard
About 429,000 portable power banks are under recall because they can overheat and potentially catch fire while charging phones, posing a burn hazard to consumers
BasePoint Expands Mental Health Services with New Clinic in Frisco, Texas
FRISCO, Texas, April 17, 2025 /PRNewswire/ -- BasePoint, a leading provider of Partial Hospitalization Programs (PHP) and Intensive Outpatient Programs (IOP) for adolescents and young adults, is expanding its reach with the opening of its fourth in-person clinic in Frisco, Texas. This new...
CDC Data Reveals Regional Disparities in Autism Diagnosis: Cognoa Advocates for Expanded Insurance Coverage
Recent CDC data reveals significant regional disparities in autism identification, highlighting the need for standardized, accessible diagnostic approaches nationwide. PALO ALTO, Calif., April 17, 2025 /PRNewswire/ -- In response to yesterday's Centers for Disease Control and Prevention...
UK Government Imposes Temporary Ban on EU Cheese and Meat to Combat Foot and Mouth Disease
The temporary measure by the government is aimed at stopping the spread of foot and mouth disease.
Intuitive's Studies Highlight the Impact of Robotic-Assisted Surgery on Patient Care Access
Studies show robotic-assisted procedures enable increased access to minimally invasive care Studies show robotic-assisted procedures enable increased access to minimally invasive care
Revolutionary Skeletal Strengthening Technology Launches in Canada
Bringing Science-Backed Skeletal Strengthening Technology to Canada OAKVILLE, ON, April 17, 2025 /PRNewswire/ -- OsteoStrong, a global leader in skeletal strength conditioning, is expanding with a new location in Oakville, Ontario, offering residents a cutting-edge, drug-free solution to...
Biomerica's Fortel Kidney Disease Test Approved for Sale in UAE, Enhancing Early Detection of CKD
IRVINE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced that its Fortel® Kidney Disease (Microalbumin) Test has been approved for sale by the United Arab Emirates (UAE) Ministry of Health and Prevention. This key regulatory milestone enables Biomerica to offer its innovative test across the UAE, a region facing a high burden of chronic kidney disease (CKD).
Cape Town's Milnerton Lagoon Faces Persistent Pollution Crisis
Campaigners say authorities should be doing more to clean up waters around city of nearly 5 million peopleOn a clear summer’s day in Cape Town, the Milnerton Lagoon was serene, reflecting the bright blue sky and Table Mountain. But there was an unmistakable stench, and up close, the water was murky.A few hundred metres away, adults and children played in the water as it flowed into Table Bay. On the boardwalk, a sign read: “Polluted water: for health reasons, swimming and recreational activities are at your own risk.” Continue reading...
Clearmind Medicine Secures Patent for MEAI Treatment Aimed at Binge Behavior
Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that the United States Patent Office has issued a Notice of Allowance for a patent relating to its MEAI treatment for binge behavior.
Could Polio Be Poised for a Comeback?
The world is so close to wiping out polio. But in 2025, there are sign that the virus is not quite ready to go the way of smallpox the only disease eradicated by humans. Two countries are seeing an … [+16769 chars]
uniQure's AMT-130 Receives Breakthrough Therapy Designation for Huntingtons Disease
~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~
Regeneron Receives FDA Priority Review for EYLEA HD's Expanded Dosing Options in Treating Retinal Vein Occlusion
If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated for all other anti-VEGF therapies
Eli Lilly's Experimental Obesity Pill Shows Promising Results in Late-Stage Trials
The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.
Breakthrough in Diabetes and Obesity Treatment: The Promise of Orforglipron
Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
Ligand Pharmaceuticals and Channel Therapeutics Announce Merger to Launch ZELSUVMI
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
Crownsville State Hospital: A Somber Reflection of Maryland's Segregated Past
The former Hospital for the Negro Insane of Maryland was once the state’s most crowded psychiatric institution. Pulling off a plan to redevelop it won’t be easy.
The Struggle of Psychiatric Patients: A Cycle of Homelessness and Insufficient Care
When L tells the story of her mom and how she's stuck in a repetitive cycle of mental health crises and bouts of homelessness she refers to a thick stack of papers and notes she's accumulated along t… [+9836 chars]
Henlius Hosts Global R&D Day 2025: A Collaborative Approach to Pioneering Cancer Therapies
SHANGHAI, April 17, 2025 /PRNewswire/ -- Henlius (2696.HK) held its 2025 Global R&D Day themed "Collaborate to Create," gathering senior executives, experts, and industry leaders to discuss R&D advances, strategic planning, and cutting-edge therapies. The event attracted hundreds from...
Can a Night in a Laboratory Improve Sleep Quality?
Robby WestReporting from University of East Anglia BBC reporter Robby West spent the night at the University of East Anglia's Sleep and Brain Research Unit Do you get enough sleep? As a new parent… [+6654 chars]
Patient's Frustration with Therapist's Time Management Sparks Concern
"And it went like that: she'd log on, flustered, and ask why I was late. It was pretty obvious from her tone, body language, and how defensive she was that she knew she was screwing up and just didn'… [+314 chars]
Mesoblast Expands Coverage for Groundbreaking Therapy Ryoncil to 104 Million Lives in the U.S.
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has continued to expand coverage for Ryoncil® (remestemcel-L), the first mesenchymal stromal cell (MSC) therapy approved by U.S. Food and Drug Administration (FDA) for any indication, to 104 million US lives insured by government and commercial payers.
Arkansas Becomes First State to Ban Pharmacy Benefit Managers from Owning Pharmacies
Arkansas has enacted a law making it the first state banning pharmacy benefit managers from owning a pharmacy in the state. Gov.
Climate Change Poses Threat to Global Blood Supply, New Study Reveals
Extreme weather disasters, increasing as the planet warms, can curb blood donations while increasing demand, a new analysis found.
World Health Organization Reaches Agreement on Pandemic Treaty After Prolonged Negotiations
The World Health Organization finally reached a compromise on a pandemic treaty after three years of talks. The United States withdrew from negotiations after President Trump took office.
Federal Experts Recommend Expansion of RSV Vaccinations and New Meningitis Shot
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis
Elicio Therapeutics Secures New Talent with Inducement Awards
BOSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that on April 15, 2025, Elicio granted inducement awards to Elicio’s newly appointed Chief Strategy and Financial Officer, Preetam Shah, and two additional new employees, as an inducement material to Dr. Shah and such employees entering into employment with Elicio in accordance with Nasdaq Listing Rule 5635(c)(4), which grants were approved by the compensation committee of Elicio’s board of directors in accordance with the Elicio 2024 Inducement Incentive Award Plan.
Annexon, Inc. Grants Inducement Award to New Non-Executive Employee
BRISBANE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that it has granted inducement to a new non-executive employee under the terms of the 2022 Employment Inducement Award Plan. The equity award was approved on April 11, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4).
The Giorgio Foundation and University of Pittsburgh Establish $2 Million Endowed Chair to Advance NF1 Research
PITTSBURGH, April 16, 2025 /PRNewswire/ -- The Giorgio Foundation and the University of Pittsburgh announce the establishment of The Giorgio Foundation Endowed Chair in the School of Medicine's Department of Neurosurgery with a total commitment of $2 million. This gift will support...
Boost Your Kidney Health with These 13 Superfoods
It's common knowledge that you can live a fulfilling life with just one kidney, but are you aware of what your kidneys actually do? The US Centers for Disease Control and Prevention estimate that ove… [+5659 chars]
Scilex Holding Company Receives FDA Approval for Gloperba as First Liquid Colchicine for Gout and Pericarditis Treatment
PALO ALTO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that FDA has approved our request for the Orphan drug designation for colchicine for the treatment of pericarditis.
Valneva SE to Showcase Innovations at 25th World Vaccine Congress in Washington, D.C.
Saint-Herblain (France), April 16, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place from April 21-24, 2025 at the Walter E. convention center in Washington, D.C. Under the leadership of the Company´s Chief Executive Officer, Thomas Lingelbach, a team of Valneva´s senior managers will participate in multiple events, including an important presentation on the Company´s vaccine IXCHIQ®, the world’s first licensed chikungunya vaccine.
Valneva to Showcase Innovations at the 25th World Vaccine Congress in Washington, D.C.
Saint-Herblain (France), le 16 avril 2025 - Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui sa présence au 25ème World Vaccine Congress, qui se tiendra du 21 au 24 avril 2025 au Walter E. Convention Center à Washington, D.C. Sous la direction du directeur général de la Société, Thomas Lingelbach, des membres de l’équipe dirigeante de Valneva participeront à de nombreux événements, dont une présentation sur le vaccin IXCHIQ®, premier vaccin homologué au monde contre le chikungunya.
Webinar Series to Address Airborne Toxins and Rising Rates of Immune-Related Illnesses
Healthcare providers and wellness advocates are invited to explore how airborne toxins may be triggering the rising rates of immune-related illness BUFFALO, N.Y., April 16, 2025 /PRNewswire/ -- Millions of people are living with chronic infections, autoimmune diseases, and persistent...
Henlius Unveils Comprehensive ESG Report for 2024, Showcasing Commitment to Health, Environment, and Community
SHANGHAI, April 16, 2025 /PRNewswire/ -- On April 15, 2025, Henlius (2696.HK) released the "2024 Environmental, Social, and Governance (ESG) Report" (hereinafter referred to as the "ESG Report" or "Report"). This marks the sixth consecutive year that the company has submitted an...
Spain Enforces New Healthy Eating Regulations in Schools
Rules brought in this week limit amounts of fatty and fried food and levels of sugar and caffeine in drinksAll schools in Spain will be legally obliged to serve fruit and vegetables as part of their lunches and fish at least once a week under new rules aimed at reducing the amount of fried and fatty food served to children.Hailed by the government as a key plank of the fight against childhood obesity, the rules brought in by royal decree this week will also compel schools to offer vegetarian and vegan meals. Continue reading...
Federal Crackdown on Cheaper Weight-Loss Drugs Could Cut Access for Hundreds of Thousands
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
Rodent Nests Discovered Near Residence of Late Actor Gene Hackman and His Wife
Nests and some dead rodents were found in outbuildings of the house where Oscar-winning actor Gene Hackman and his wife Betsy Arakawa were found dead. New Mexico Department of Public Health records… [+2335 chars]
Sonnet BioTherapeutics Announces Positive Safety Data for SON-1010 in Advanced Cancer Treatment
- Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010